Market Closed

JNJ
Johnson & Johnson
$ 235.42
0.02%   Last 24H
  
Trading with leverage comes with a high risk and may not be suitable for everyone.
Add to Portfolio
Updated an hour ago

Johnson & Johnson News

Latest Johnson & Johnson Stock News & JNJ Headlines

J&J Expands New Drug Portfolio With Icotyde's FDA Approval
4 days ago | zacks.com
FDA approves psoriasis pill from J&J that rivals shots Tremfya, Skyrizi
5 days ago | cnbc.com
Johnson & Johnson (JNJ) Could Be a Great Choice
10 days ago | zacks.com
JNJ Seeks Label Expansion of Multiple Myeloma Drug Tecvayli in the EU
12 days ago | zacks.com
JNJ Gets EU Nod for Expanded Use of Akeega in Prostate Cancer
13 days ago | zacks.com
2 No-Brainer Dividend Stocks to Buy in 2026
15 days ago | fool.com
The Only Healthcare Stock I'd Buy and Never Sell Might Be Johnson & Johnson
a month ago | fool.com
TREMFYA® (guselkumab) long-term data show sustained clinical and endoscopic remission in ulcerative colitis through 3 years
a month ago | prnewswire.com
J&J to invest $1 billion in new Pennsylvania plant amid US manufacturing push
a month ago | reuters.com
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
a month ago | zacks.com
Load More

Download App

Keep track of your holdings and explore over 46,000 cryptocurrencies

CoinCodex iOS AppoinCodex Android App
CoinCodex Mobile App
Market Closed

JNJ
Johnson & Johnson
$ 235.42
0.02%   Last 24H
  
Trading with leverage comes with a high risk and may not be suitable for everyone.
Add to Portfolio
Updated an hour ago